Presentations

AI-driven Personalized Medicine for Cancer Care

January 26, 2024

Presentation Detail

  • Speaker: Ilona Holcomb, PhD, Director of Bioscience of ImpriMed, Inc.
  • Date: January 26, 2024
  • Description: ImpriMed provides an anticancer drug efficacy prediction service using artificial intelligence on a patient's live cancer cell data, aiming to help oncologists personalize a treatment regimen tailored to each patient's unique cancer in both human and veterinary oncology. ImpriMed's comparative oncology platform enables new precision medicine services for both human and animal cancers.

Presentations

Presentations
VCS Logo

Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics

Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
VCS Logo

Novel Genetic Biomarkers of Chemotherapeutic Response in Canine Lymphoma and Improved Predictive Power With Integration of Machine Learning

Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
VCS Logo

Decoding Feline Lymphoma: From Diagnosis to Prognosis

Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
SAVY Logo

Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models

Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Learn More →
Presentations
WVCC logo

Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support

World Veterinary Cancer Congress 2024
Learn More →
Presentations
WVCC Logo

Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results

World Veterinary Cancer Congress 2024
Learn More →
Presentations
Veterinary Cancer Society Logo

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society Logo

Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society logo

Impact of AI on clinical practice and outcome

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society Logo

Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen

Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care

Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023
Learn More →
Presentations
Precision Medicine World Conference logo

Reinventing precision medicine: from dogs to humans

Precision Medicine World Conference 2023
Learn More →
Presentations
Veterinary Cancer Society Logo

Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS

Veterinary Cancer Society Annual Conference 2022
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed Research Update

Veterinary Cancer Society Annual Conference 2022
Learn More →
Presentations
Veterinary Cancer Society Logo

Drugs predicted to be effective using artificial intelligence (AI) double the clinical response rate in canines with relapsed B-cell lymphoma

Veterinary Cancer Society Mid-Year Conference 2022
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed Research Update

Veterinary Cancer Society Mid-Year Conference 2022
Learn More →
Presentations
Animal Health, Nutrition and Technology Innovation Europe logo

Precision medicine for pet cancer care

Animal Health, Nutrition and Technology Innovation Europe 2022
Learn More →
Presentations
Veterinary Cancer Society Logo

Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model

Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
Veterinary Cancer Society Logo

ImpriMed: Experiences from the eyes of an oncologist in clinical practice

Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
Veterinary Cancer Society Logo

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

Veterinary Cancer Society Annual Conference 2020
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients

Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
World Veterinary Cancer Congress logo

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

World Veterinary Cancer Congress 2020
Learn More →
Presentations
Precision Medicine World Conference logo

From dog to human: precision medicine for comparative oncology

Precision Medicine World Conference 2020
Learn More →
Presentations
NYC Oncology Conference 2019

ImpriMed: precision medicine for pet cancer care

NYC Oncology Conference 2019
Learn More →
Presentations
Veterinary Cancer Society Logo

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

Veterinary Cancer Society Annual Conference 2019
Learn More →